The CFSRE’s NPS Discovery program uses a non-targeted ... synthetic opioids in recreational drug supplies and new synthetic cannabinoids in prisons. The capacity to retrospectively analyze ...

The increasing prevalence of AD and the burden of agitation in Alzheimer’s dementia for patients and caregivers alike underscore the need for new therapies that can address NPS, including ...

Stimulants continue to constitute the largest group of NPS at 35 percent, followed by synthetic cannabinoid receptor agonists (32 percent), classic hallucinogens (15 percent) and synthetic opioids (12 ...

A new study from Colombia’s Universidad de Antioquia, published in the peer reviewed journal Medical Cannabis and ...

Out of the 44 NPS reported for the first time in 2023, synthetic cannabinoids were the largest group at the global level with 14 substances, 10 of which belonged to a less well studied group of ...

The growth of novel psychoactive substances (NPS), including synthetic opioids, synthetic cannabinoids, and designer stimulants, poses new challenges to the addiction field, as their physiological ...

Researchers are attempting to spread awareness about that condition, cannabinoid hyperemesis syndrome (CHS), and the need for more government oversight in the legal cannabis industry. What is ...

The National Pension System (NPS) is a government-backed retirement savings scheme that encourages long-term financial security. However, circumstances may arise where individuals need access to ...

Effin' products are formulated combinations of THC and minor cannabinoids like THCV, CBN, CBG, and CBD. The New Jersey-based company said Effin’ focuses on delivering specific effects through ...

They may work with the plant’s cannabinoids and other compounds to produce medicinal effects. Terpenes are naturally occurring chemical compounds found in plants and some animals. They’re ...